Bioactive Precision Peptides™ are AI-discovered, plant-derived peptides backed by 18+ randomized, double-blind, placebo-controlled clinical trials published in peer-reviewed journals.
MAKE Wellness uses a proprietary machine learning platform to identify bioactive peptides from natural plant sources — 10× faster and 600× more accurate than traditional discovery methods. The AI screens thousands of natural compounds, applies biochemical filters, and validates candidates through a rigorous 6-step process before any human trial begins.
Peptides are information carriers — they carry biological information from one cell to another for everything in the body to function correctly. At least 7,000 peptides are found in the human body, and DNA itself is a matrix of inactive information waiting for peptides to deliver up-regulating or down-regulating messages to genes.
Each formula targets a distinct biological pathway. Click any card to expand the full mechanism and clinical benefit breakdown.
All human trials listed are randomized, double-blind, and placebo-controlled unless otherwise noted. Full protocols, participant numbers, endpoints, and p-values are available upon request.
The science behind Bioactive Precision Peptides™ is authored by a team of PhDs and AI researchers whose combined work spans peptide biochemistry, clinical nutrition, machine learning, and pharmaceutical formulation.
Dr. Nora Khaldi founded Nuritas, a world-leading AI-driven bioactive peptide discovery company, and serves as Chief Science Officer at MAKE Wellness. Her proprietary machine learning platform screens thousands of natural plant compounds to identify novel bioactive peptides at 10× the speed and 600× the accuracy of traditional discovery methods.
Dr. Khaldi's platform applies a rigorous 6-step process — from biochemical pathway mapping through cell-level confirmation to human clinical validation — before any peptide enters a MAKE Wellness formula. Her work has been published in leading peer-reviewed journals and has attracted investment from some of the world's largest food and pharmaceutical companies.
Dr. Bartlett is the primary author of the MAKE Wellness clinical research reviews, including the peer-reviewed 'Fit with Peptistrong Plus' and 'Lean with Apticurb Trimfast Complex' papers. His work focuses on translating AI-discovered peptide candidates into clinically validated nutritional formulations, with a particular emphasis on mTOR activation, myostatin inhibition, and metabolic pathway modulation.
Dr. Jones specializes in the metabolic and lipolytic mechanisms underlying the LEAN and ENERGIZED formulas. His research examines how bioactive peptides modulate the gut-brain axis — regulating ghrelin, leptin, and NPY — to produce clinically measurable reductions in fat mass without lean muscle loss. He co-authored the BPP clinical studies summary covering 18 randomized controlled trials.
Dr. Milks bridges the gap between complex peptide biochemistry and pharmacy-level clinical education. She authored the comprehensive 'Bioactive Precision Peptides — Mechanisms, Efficacy, and Clinicals' presentation used to train pharmacy partners, covering all five formulas (FIT, LEAN, ENERGIZED, FOCUSED, HYDRATED) with pathway diagrams, clinical trial data, and patient-facing benefit summaries.
Every product in the Bioactive Precision Peptides portfolio meets the highest standards for purity, safety, and efficacy.
Partner with Precision Peptide Partners to offer clinically validated, AI-discovered bioactive peptides through your independent pharmacy.